Agilent Expands Spectroscopy Business by Acquiring Specific Assets of A2 Technologies

Agilent Technologies Inc. (NYSE: A) has completed the acquisition of specific assets of A2 Technologies. Financial details were not disclosed for the acquisition, which was first announced Jan. 19.

The acquisition supports Agilent’s goal of expanding its spectroscopy business. Substantially all of A2 Technologies’ intellectual property, technology and spectroscopy product portfolio are now part of Agilent’s Spectroscopy Solutions Division within its Chemical Analysis Group. All former A2 Technologies employees have joined Agilent.

Headquartered in Danbury, Conn., A2 Technologies focused on Fourier transform infrared (FT-IR) technology for lab and field use. The company designed, developed and manufactured FT-IR spectrometers for routine analysis and out-of-lab applications in the petrochemical, environmental, aerospace, art conservation, academia and geosciences markets. Unique, patented technologies acquired from A2 provide high-performance analytical capabilities in a compact form.

Source: http://www.home.agilent.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Agilent Technologies Inc.. (2019, February 12). Agilent Expands Spectroscopy Business by Acquiring Specific Assets of A2 Technologies. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=21572.

  • MLA

    Agilent Technologies Inc.. "Agilent Expands Spectroscopy Business by Acquiring Specific Assets of A2 Technologies". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=21572>.

  • Chicago

    Agilent Technologies Inc.. "Agilent Expands Spectroscopy Business by Acquiring Specific Assets of A2 Technologies". AZoNano. https://www.azonano.com/news.aspx?newsID=21572. (accessed November 21, 2024).

  • Harvard

    Agilent Technologies Inc.. 2019. Agilent Expands Spectroscopy Business by Acquiring Specific Assets of A2 Technologies. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=21572.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.